Ankylosing Spondylitis Treatment after First Anti-TNF Drug Failure

Isr Med Assoc J. 2018 Feb;20(2):119-122.

Authors

Maurizio Benucci¹, Arianna Damiani¹, Francesca Bandinelli¹, Valentina Grossi², Maria Infantino², Mariangela Manfredi², Francesca Li Gobbi¹, Piercarlo Sarzi-Puttini³, Fabiola Atzeni³

Affiliations

¹ Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.
² Immunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, Florence, Italy.
³ Rheumatology Unit, Sacco University Hospital, Milan, Italy.

PMID: 29431309

No abstract available

Publication types

Review

MeSH terms

Antirheumatic Agents / adverse effects
Antirheumatic Agents / pharmacology
Antirheumatic Agents / therapeutic use*
Humans
Medication Adherence
Spondylitis, Ankylosing / drug therapy*
Spondylitis, Ankylosing / physiopathology
Treatment Failure
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antirheumatic Agents
Tumor Necrosis Factor-alpha